Moreover, other authors reported that downregulation of the HO-1 system is involved in mediating antiangiogenic effects of ellagic acid in prostate cancer [21] and reduces the migratory and invasive abilities of A549 cells upon resveratrol treatment [22]. The gene discussed is HMOX1; the disease is prostate carcinoma.